Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Curis Inc CRIS

Sector: Healthcare | Sub-Sector: Biotechnology

Curis, Inc., is a drug discovery and development company. The Company is engaged in the development of its proprietary targeted cancer drug candidates, including CUDC-907, HDAC and phosphatidylinositol-3-kinase, or PI3K.
Price: $1.67 | Change: $-0.02 | %Change: -1.18%
Volume: 935,197 | Day High/Low: 1.70/1.64 | 52 Week High/Low: 4.74/1.60

Snapshot

Last Traded: July 18, 2014 12:00 Transaction Volume: 935,197
Open: $1.67 Previous Close: $1.69
Bid: N/A Ask: N/A
Bid Size: 0 Ask Size: 0
Market Cap: $143.5m Shares Out: 85.9m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts